by Amidst ongoing concerns regarding the potential impact of COVID-19 vaccines on pregnancy outcomes, a recent study published in the journal “EClinicalMedicine” has provided some reassuring findings. The research, led by scientists from the University of Birmingham in the United Kingdom, aimed to investigate any association between COVID-19 Vaccines and stillbirths.
The team analyzed data from the UK’s National Health Service (NHS) and the Public Health England’s (PHE) enhanced surveillance system for adverse events following immunization. They identified 1,115 stillbirths that occurred between December 8, 2020, and July 15, 2021, and compared them to a control group of 4,460 live births.
The study found no significant difference in the risk of stillbirths between those who had received a COVID-19 Vaccine and those who had not. The researchers noted that the rate of stillbirths was consistently low throughout the study period, regardless of vaccination status.
Dr. Mary Ramsay, Head of Immunization at PHE, commented on the findings, stating, “This study provides important reassurance for pregnant women and their healthcare providers. The benefits of COVID-19 vaccines far outweigh any known risks, and it’s crucial that pregnant women continue to get vaccinated to protect themselves and their babies from COVID-19.”
The study’s authors emphasized that while their findings are promising, more research is needed to fully understand the safety profile of COVID-19 vaccines during pregnancy. They encouraged pregnant women to discuss any concerns they may have with their healthcare providers and to get vaccinated against COVID-19 to protect their health and the health of their babies.
The new study published in “EClinicalMedicine” offers reassuring evidence that there is no significant association between COVID-19 vaccines and stillbirths. The findings add to the growing body of evidence supporting the safety and efficacy of COVID-19 vaccines for pregnant women.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
